Vericel Corp. (VCEL)

[hurley cruppers]

VCEL mentioned FIRST in research report

ALBANY, New York, January 4, 2017 /PRNewswire/ --

The leading players operating in the Global Autologous Cell Therapy Market are Vericel Corporation, BioTime, Inc., Pharmicell Co., BrainStorm Cell Therapeutics, Opexa Therapeutics, Inc, Pharmicell Co., Inc. These companies are expected to focus on mergers and acquisitions to enter local markets, observes Transparency Market Research. Furthermore, efforts to establish subsidiaries and manufacturing centers in emerging economies are also expected to make the global market exceptionally competitive in the coming few years.

According to the research report, the global autologous cell therapy market is expected to be worth US$23.7 bn by the end of 2024 as compared to US$3.8 bn in 2015. During the forecast period of 2016 and 2024, the global market is estimated to exhibit a CAGR of 21.9%.


http://www.prnewswire.com/news-releases/global-autologous-cell-therapy-market-development-of-bone-marrow-based-products-ensures-whopping-219-cagr-by-2024-observes-tmr-609627045.html

VCEL